Pfizer says they are working on Omicron specific vaccine if needed.
Pfizer and BioNTech says its preliminary lab tests suggest a third dose of its vaccine is providing strong protection agains the Omicron variant.
With health officials urging people to get a third dose, Pfizer has released a study on whether booster shots of its COVID-19 vaccine may make an important difference.
The company says a booster dose may offer significant protection against the new Omicron variant even though the initial two doses appear significantly less effective.
Pfizer-BioNTech says its already working on creating an Omicron-specific vaccine and could have it ready for March of 2022 if needed.
Niagara Falls Exploring Pothole Repair Idea
Advocates Want Formerly Homeless for Committee
Niagara Falls Preps for Ribfest
Hospital Deficits Getting Worse: Report
Man Dies in Lincoln House Fire
Potential Niagara Parks Strike
Man Charged with Possessing Child Porn
Be Wary of Spring Time Scams: NRP